OTCMKTS:ARYC

Arrayit - ARYC Stock Forecast, Price & News

Add

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 1 shs
Average Volume: 35,000 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Institutional Ownership

Headlines

SEC Filings

Short Interest

About Arrayit (OTCMKTS:ARYC) Stock

Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.

Receive ARYC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arrayit and its competitors with MarketBeat's FREE daily newsletter.

ARYC Stock News Headlines

December 26, 2022 | reuters.com

aryc.pk - Arrayit Corp | Stock Price & Latest News | Reuters

September 21, 2022 | benzinga.com

Insights on the IoT Healthcare Global Market to 2028 - North America is Projected to Hold a Significant S - Benzinga

March 26, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.

September 14, 2022 | bloomberg.com

Microarray Market to Reach $8.4 Billion, Globally, by 2031 at 7.8% CAGR: Allied Market Research - Bloomberg

September 2, 2022 | nytimes.com

California Biotech Executive Is Guilty in $77 Million Blood-Testing Scheme - The New York Times

August 13, 2022 | ca.finance.yahoo.com

Arrayit Corporation (ARYC)

July 27, 2022 | benzinga.com

Global Immunoassay Market Report 2022-2027 with Profiles of 58 Companies - Benzinga - Benzinga

July 27, 2022 | finance.yahoo.com

Microarray Analysis Market to Surpass $9,011.1 Million Value by 2030, says P&S Intelligence - Yahoo Finance

March 26, 2023 | Investor Place Media (Ad)

Biden To Unleash "Choke Point" Operation On America?

July 27, 2022 | finance.yahoo.com

Global Immunoassay Market Report 2022-2027 with Profiles of 58 Companies - Yahoo Finance

July 25, 2022 | businesswire.com

Global Immunoassay Market Strategies, Trends, Forecasts Report 2022-2027: Multiplex and Point of Care Market Analysis, Executive Guides, Customized Forecasting and Analysis - ResearchAndMarkets.com - Business Wire

July 22, 2022 | finance.yahoo.com

Global Immunoassay Market Strategies, Trends, Forecasts 2022-2027: The Genetic Blizzard and the Move to Point of Care Drive Dramatic Change for Traditional Immunoassay Technology - Yahoo Finance

July 22, 2022 | benzinga.com

Global Immunoassay Market Strategies, Trends, Forecasts 2022-2027: The Genetic Blizzard and the Move to P - Benzinga

April 20, 2022 | latimes.com

7 Californians among those charged in $150-million COVID fraud - Los Angeles Times

January 25, 2022 | finance.yahoo.com

Worldwide Microarray Industry to 2027 - Key Motivators, Restraints and Opportunities - ResearchAndMarkets.com - Yahoo Finance

January 20, 2022 | uk.finance.yahoo.com

Global COVID-19 EIA/ELISA Medical Devices Pipeline Landscape Report 2021: Product Description, Licensing and Collaboration Details and Other Developmental Activities - Yahoo Finance UK

January 20, 2022 | globenewswire.com

Global COVID-19 EIA/ELISA Medical Devices Pipeline Landscape Report 2021 - GlobeNewswire

January 12, 2022 | finance.yahoo.com

Microarray Analysis Market to grow by USD 1.62 bn at 5.94% CAGR from 2021 to 2026|Evolving Opportunities with Agilent Technologies Inc., Applied Microarrays Inc. & Arrayit Corp | 17000+ Technavio Reports - Yahoo Finance

December 7, 2021 | benzinga.com

Tissue Microarray Market to grow at a CAGR of 7.75% by 2026 |Hospitals Segment to be Significant for Reve - Benzinga

November 22, 2021 | globenewswire.com

Protein Chip Market Predicted to Reach $1.36 Billion by 2030, Exclusive Report by Allied Market Research - GlobeNewswire

November 3, 2021 | finance.yahoo.com

Microarray Market to Record USD 1.21 Bn Growth | Almost 6% CAGR Projection Through 2025 | 17,000+ Technavio Reports - Yahoo Finance

October 21, 2021 | businesswire.com

Global DNA Microarray Markets, 2021-2025 - Advances in Technology and the Growing Importance in Therapeutics - ResearchAndMarkets.com - Business Wire

October 4, 2021 | finance.yahoo.com

The Global DNA Microarray Market is expected to grow by $ 2.61 bn during 2021-2025, progressing at a CAGR of 12.00% during the forecast period - Yahoo Finance

May 27, 2021 | msn.com

Feds expand COVID-related fraud case against Sunnyvale lab company Arrayit - msnNOW

April 9, 2021 | businesswire.com

Global COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Medical Device Pipeline Market Assessment 2020-2021 - ResearchAndMarkets.com - Business Wire

February 11, 2021 | globenewswire.com

Microarray Market Value to Surpass USD 8.15 Billion by 2030 - GlobeNewswire

November 28, 2020 | markets.businessinsider.com

News for Arrayit Corp

See More Headlines

Receive ARYC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arrayit and its competitors with MarketBeat's FREE daily newsletter.

ARYC Company Calendar

Today: 3/26/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:ARYC
CUSIP: N/A
CIK: 1084507
Web: www.arrayit.com
Phone: (408) 744-1331
Fax: 408-744-1711
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: -0.48

Key Executives

Rene A. Schena
Chairman & Chief Executive Officer

Mark Schena
President, Secretary, Treasurer & Director

Todd J. Martinsky
Director, Chief Technology Officer & EVP

Key Competitors

View All Competitors

ARYC Stock - Frequently Asked Questions

What other stocks do shareholders of Arrayit own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Arrayit investors own include Western Alliance Bancorporation (WAL), Mr. Cooper Group (COOP), Pacific Biosciences of California (PACB), WMIH (WMIH), Actinium Pharmaceuticals (ATNM), MICT (MICT), PolyMet Mining (PLM), Uni-Pixel (UNXLQ) and
What is Arrayit's stock symbol?: Arrayit trades on the OTCMKTS under the ticker symbol "ARYC."
How do I buy shares of Arrayit?: Shares of ARYC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
How can I contact Arrayit?: Arrayit's mailing address is 927 THOMPSON PLACE, SUNNYVALE CA, 94085. The official website for the company is www.arrayit.com. The company can be reached via phone at (408) 744-1331, via email at investorrelations@arrayit.com, or via fax at 408-744-1711.

This page (OTCMKTS:ARYC) was last updated on 3/26/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial